Literature DB >> 18467641

Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET.

Claudia Calcagno1, Jean-Christophe Cornily, Fabien Hyafil, James H F Rudd, Karen C Briley-Saebo, Venkatesh Mani, Gregg Goldschlager, Josef Machac, Valentin Fuster, Zahi A Fayad.   

Abstract

OBJECTIVE: The association of inflammatory cells and neovessels in atherosclerosis is considered a histological hallmark of high-risk active lesions. Therefore, the development and validation of noninvasive imaging techniques that allow for the detection of inflammation and neoangiogenesis in atherosclerosis would be of major clinical interest. Our aim was to test 2 techniques, black blood dynamic contrast enhanced MRI (DCE-MRI) and 18-fluorine-fluorodeoxyglucose (18F-FDG) PET, to quantify inflammation expressed as plaque neovessels content in a rabbit model of atherosclerosis. METHODS AND
RESULTS: Atherosclerotic plaques were induced in the aorta of 10 rabbits by a combination of 2 endothelial abrasions and 4 months hyperlipidemic diet. Six rabbits underwent MRI during the injection of Gd-DTPA, whereas 4 rabbits were imaged after injection of 18F-FDG with PET. We found a positive correlation between neovessels count in atherosclerotic plaques and (1) Gd-DTPA uptake parameters evaluated by DCE-MRI (r=0.89, P=0.016) and (2) 18F-FDG uptake evaluated by PET (r=0.5, P=0.103 after clustered robust, Huber-White, standard errors analysis).
CONCLUSIONS: DCE-MRI and 18F-FDG PET may allow for the evaluation of inflammation in atherosclerotic plaques of rabbits. These noninvasive imaging modalities could be proposed as clinical tools in the evaluation of lesion prognosis and monitoring of anti-angiogenic therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467641      PMCID: PMC3194007          DOI: 10.1161/ATVBAHA.108.166173

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

Review 1.  Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging.

Authors:  Valentin Fuster; Zahi A Fayad; Pedro R Moreno; Michael Poon; Roberto Corti; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-10-04       Impact factor: 24.094

2.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model.

Authors:  Thomas E Yankeelov; Jeffrey J Luci; Martin Lepage; Rui Li; Laura Debusk; P Charles Lin; Ronald R Price; John C Gore
Journal:  Magn Reson Imaging       Date:  2005-05       Impact factor: 2.546

3.  Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data.

Authors:  Thomas E Yankeelov; Greg O Cron; Christina L Addison; Julia C Wallace; Ruth C Wilkins; Bruce A Pappas; Giles E Santyr; John C Gore
Journal:  Magn Reson Med       Date:  2007-02       Impact factor: 4.668

Review 4.  Neovascularization in human atherosclerosis.

Authors:  P R Moreno; K R Purushothaman; E Zias; J Sanz; V Fuster
Journal:  Curr Mol Med       Date:  2006-08       Impact factor: 2.222

Review 5.  Links between inflammation and thrombogenicity in atherosclerosis.

Authors:  J F Viles-Gonzalez; V Fuster; J J Badimon
Journal:  Curr Mol Med       Date:  2006-08       Impact factor: 2.222

6.  Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.

Authors:  William S Kerwin; Kevin D O'Brien; Marina S Ferguson; Nayak Polissar; Thomas S Hatsukami; Chun Yuan
Journal:  Radiology       Date:  2006-09-11       Impact factor: 11.105

7.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

Review 8.  Atherothrombosis and high-risk plaque: part I: evolving concepts.

Authors:  Valentin Fuster; Pedro R Moreno; Zahi A Fayad; Roberto Corti; Juan J Badimon
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

Review 9.  Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.

Authors:  Anwar R Padhani
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  66 in total

1.  Assessment of atherosclerotic plaques in a rabbit model by delayed-phase contrast-enhanced CT angiography: comparison with histopathology.

Authors:  Jin Hur; Young Jin Kim; Hyo Sup Shim; Hye-Jeong Lee; Ji Eun Nam; Kyu Ok Choe; Byoung Wook Choi
Journal:  Int J Cardiovasc Imaging       Date:  2011-01-30       Impact factor: 2.357

2.  Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability.

Authors:  Stephan Metz; Ambros J Beer; Marcus Settles; Jaroslav Pelisek; René M Botnar; Ernst J Rummeny; Peter Heider
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

Review 3.  Noninvasive imaging of atheromatous carotid plaques.

Authors:  Umar Sadat; Zhi-Yong Li; Martin J Graves; Tjun Y Tang; Jonathan H Gillard
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

4.  Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.

Authors:  A Millon; S D Dickson; A Klink; D Izquierdo-Garcia; J Bini; E Lancelot; S Ballet; P Robert; J Mateo de Castro; C Corot; Z A Fayad
Journal:  Atherosclerosis       Date:  2013-03-26       Impact factor: 5.162

Review 5.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

Review 6.  Magnetic [corrected] resonance imaging [corrected] features of the disruption-prone and the disrupted carotid plaque.

Authors:  Baocheng Chu; Marina S Ferguson; Huijun Chen; Daniel S Hippe; William S Kerwin; Gador Canton; Chun Yuan; Thomas S Hatsukami
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

7.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

8.  Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.

Authors:  Claudia Calcagno; Zahi A Fayad
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

9.  Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.

Authors:  Alkystis Phinikaridou; Marcelo E Andia; Begoña Lavin; Alberto Smith; Prakash Saha; René M Botnar
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

10.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Authors:  Matthias Nahrendorf; Edmund Keliher; Peter Panizzi; Hanwen Zhang; Sheena Hembrador; Jose-Luiz Figueiredo; Elena Aikawa; Kimberly Kelly; Peter Libby; Ralph Weissleder
Journal:  JACC Cardiovasc Imaging       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.